Structural elucidation,antioxidant and hepatoprotective activities of chemical composition from Jinsi Huangju (Chrysanthemum morifolium) flowers

Six new compounds (huangjusus A-F), including three caffeic acid glycosides (1–3), one quinic acid derivative (4), one dihydroflavone glycoside (11) and one monoterpene (31), together with thirty-eight known compounds (5–10, 12–30, 32–44), were obtained from “Jinsi Huangju” (Chrysanthemum morifolium Ramat.) flowers. Their structures were elucidated on the basis of the data obtained from different spectroscopic techniques. Among these compounds, five new (1–4 and 11) and ten known (5–9, 12, 13, 17, 40, and 42) compounds demonstrated significant 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical scavenging effects with IC₅₀ values of 4.22–19.90 μM. Furthermore, three new compounds (1, 11, and 31) and seven known compounds (13, 19, 21, 29, 30, 39, and 41) exhibited potent hepatoprotective activities against N-acetyl-p-aminophenol (APAP)-induced toxicity in HepG2 cells with the cell survival rates of 61.53 %, 63.55 %, 60.01 %, 63.05 %, 59.75 %, 59.15 %, 61.07 %, 62.72 %, 58.86 %, and 58.76 % (positive control bicyclol, 58.41 %), respectively, at a concentration of 10 μM. These results indicate the potency of the flowers against radicals and in hepatoprotections.     

Synthesis, variable temperature NMR investigations and solid state characterization of novel octafluorofluorene compounds

The preparation of a number of new 9-substituted octafluorofluorene derivatives, solution NMR studies, and the first examples of solid state structures of octafluorofluorenes [1,2,3,4,5,6,7,8-octafluorofluorene, C₁₃H₂F₈, 1; 1,2,3,4,5,6,7,8-octafluoro-9-(pentafluoro)phenylfluorene, C₁₉HF₁₃, 8; 1,1′,2,2′,3,3′,4,4′,5,5′,6,6′,7,7′,8,8′-hexadecafluoro-9,9′-bifluorenyl, C₂₆H₂F₁₆, 11] are reported. Variable temperature ¹⁹F NMR investigations have been performed on the 9-aryl substituted compounds 1,2,3,4,5,6,7,8-octafluoro-9-(pentafluoro)phenyl-9-hydroxyfluorene, C₁₉HF₁₃O, 4, 1,2,3,4,5,6,7,8-octafluoro-9-(nonafluoro-4′-biphenylyl)-9-hydroxyfluorene, C₂₅HF₁₇O, 5, and 8, and the energetic barriers to rotation of the aryl have been determined. A lower rotational barrier is observed for compound 4 with respect to compound 8, while 5 does not show fluxional behaviour below 338 K. The results of the variable temperature experiments performed on 8 have been rationalized by 2D NMR studies, and compared to the solid state data resulting from the X-ray structural analysis.     

Synthesis and anti-tumor activity evaluation of novel podophyllotoxin derivatives

In order to investigate the effects on the cytotoxicity of indole-3-oxalylamino podophyllotoxin analogs, seven novel podophyllotoxin derivatives were synthesized.The compounds were tested against Hela, K562 or K562/A02 cancer cells in vitro,four of which showed significant cytotoxicity.Among them 9a,9b and 9c were superior to the positive control VP-16.     

Design,synthesis, crystal structures and biological evaluation of some 1,3-thiazolidin-4-ones as dual CDK2/EGFR potent inhibitors with potential apoptotic antiproliferative effects

A series of novel thiazolidine-4-one derivatives was synthesized by reacting 1,4-disubstituted hydrazine carbothioamides with diethyl azodicarboxylate. The structures were confirmed by spectroscopic data as well as single-crystal X-ray analyses. The antiproliferative activity of the synthesized compounds was investigated against four human cancer cell lines using an MTT assay. Compounds 5d, 5e, and 5f revealed the most potent antiproliferative activity with GI₅₀ values ranging from 0.70 µM to 1.20 µM, compared to doxorubicin GI₅₀ value = 1.10 µM. Compounds 5d, 5e, and 5f were further investigated for their inhibitory activities against CDK2 and EGFR as potential targets for their molecular mechanism. Compounds 5e and 5f have showed potent inhibitory activity to CDK2 enzyme with IC₅₀ values of 18 and 14 nM, which is more potent than the reference dinaciclib (IC₅₀ = 20 nM). Moreover, compounds 5e and 5f were the most potent EGFR inhibitors, with IC₅₀ values of 93 and 87 nM, respectively, compared to the reference erlotinib (IC₅₀ = 70 nM). In addition, the most potent derivatives were tested for their apoptotic activity against caspases 3, 8, and 9, and the results showed that compounds 5d, 5e, and 5f revealed a greater increase in active caspases 3,8 and 9 than doxorubicin. Also, compounds 5d, 5e, and 5f elevated cytochrome C levels in the MCF-7 human breast cancer cell line by about 15.5, 15.8, and 16.5 times, respectively. Finally, a molecular docking study was performed to investigate the binding sites of these compounds within the active sites of CDK2 and EGFR targets, and the results confirmed that the most potent CDK2 and EGFR inhibitor 5h also have showed the highest docking score.     

Design,synthesis and antiviral activities of chalcone derivatives containing pyrimidine

A series of chalcone derivatives (T1-T23) containing pyrimidine were synthesized, characterized, and assessed for their antiviral activity against tobacco mosaic virus (TMV) activities. Most target compounds displayed better antiviral activities against TMV than commercial ningnanmycin. Among them, the EC₅₀ value of curative activities of compounds T1, T7, T9 and T19 (219.2, 228.2, 279.9 and 234.9 μg/mL, respectively) were superior to that of ningnanmycin (320.1 μg/mL). In addtion, the EC₅₀ value of protective activities of compounds T5, T9, T19 and T23 (235.0, 220.0, 199.5 and 187.2 μg/mL, respectively) were superior to that of ningnanmycin (307.4 μg/mL). Then, the antiviral mechanism of T19 and TMV coat protein (TMV-CP) was preliminarily investigated by microscale thermophoresis (MST) and molecular docking technology. The results showed that T19 had a strong binding affinity for TMV coat protein, and its dissociation constant (K_d) was 0.00310 ± 0.000916 μM, which was superior to ningnanmycin(0.165 ± 0.0799 μM). This study suggests that chalcone derivatives containing pyrimidine could be used as novel antiviral agents for controlling the plant viruses.     

DNA binding,docking studies,artificial nuclease activity and in vitro cytotoxicity of newly synthesized steroidal 1H–pyrimidines

A new series of steroidal pyrimidines (7–9) has been synthesized by reacting steroidal thiosemicarbazones (4–6) with ethyl cyanoacetate. The compounds were characterized by IR, ¹H NMR, ¹³C NMR, MS and analytical data. The interaction studies of compounds 7–9 with DNA were carried out by UV–vis and luminescence spectroscopy. Compounds (7–9) bind to DNA preferentially through electrostatic and hydrophobic interactions, with K_b values found to be 6.56 × 10³ M⁻¹, 1.54 × 10⁴ M⁻¹ and 9.34 × 10³ M⁻¹, respectively, indicating the higher binding affinity of compound 8 towards DNA. Gel electrophoresis pattern demonstrated that compound 8 shows strong interaction with DNA and that, during its cleavage activity with pBR322 DNA, it seems to follow the mechanistic pathway involving the generation of singlet oxygen and a superoxide anion, which are responsible for initiating DNA strand scission. The docking study suggested that the intercalation of compounds in between the nucleotide base pairs is due to the presence of a pyrimidine moiety in the steroid molecule. MTT assay was carried out to check the toxicity of new compounds 7–9 against the different human cancer as well as non-cancer cell lines A545, MCF-7, HeLa, HL-60, SW480, HepG2, HT-29, A549, 184B5, MCF10A, NL-20, HPC, and HPLF. Apoptotic degradation of DNA in the presence of steroidal pyrimidines 7–9 was analysed by agarose gel electrophoresis and visualized by ethidium bromide staining (comet assay).     

Ultrasound assisted,VOSO4 catalyzed synthesis of 4-thiazolidinones: Antimicrobial evaluation of indazole-4-thiazolidinone derivatives

A simple and expedient multicomponent protocol was developed to synthesize 4-thiazolidinones by employing VOSO₄ as a catalyst under ultrasonic irradiation. The significant features of this protocol includes shorter reaction time, high yields, low catalyst loading, and also the catalyst can be recovered and reused up to next four cycles without significant loss in catalytic activity. All the synthesized novel indazole compounds were evaluated for their antibacterial and anti-biofilm activities. Compounds 9n, 9o and 9q showed promising activity (MIC value of 3.9?µg/mL) against K. planticola (MTCC 530). They also exhibited significant bactericidal activity against K. planticola (MTCC 530) (MBC value of 15.6?µg/mL). Additionally, 9n, 9o and 9q inhibited biofilm formation (IC₅₀ values ranging between 20.28–20.79?μg/mL) in this organism.     

Configurationally and conformationally homogeneous cyclic n-aryl sulfimides—IV : Synthesis,configuration and stereochemistry of the rearrangement of 1,3-di-thiane-1-N-p-chlorophenylimides

1,3-Dithiane-1-N-p-chlorophenylimides (1,4-9) were prepared and their configuration and conformation was determined by ¹H and ¹³C NMR. The compounds were rearranged to the corresponding 2-(2'-amino-5'-chlorophenyl)-1, 3-dithianes (1U,4U,9U). The rearrangement reactions took place with ?95% stereospecifity. The mechanism of the reaction was investigated with the aid of analogs specifically deuterated at C-2.     

Takaneones A-C, prenylated butylphloroglucinol derivatives from Hypericum sikokumontanum

Three new prenylated butylphloroglucinol derivatives, takaneones A-C (1-3), were isolated from the MeOH extracts of the aerial parts of Hypericum sikokumontanum together with two new prenylated phloroglucinol derivatives, takaneols A and B (4 and 5). The structures of the isolated compounds were elucidated by exhaustive spectroscopic analysis. The cytotoxicities of the isolated compounds against human cancer cell lines were evaluated. Compounds 2-4 showed cytotoxicities against K562/Adr multi-drug resistant (MDR) cancer cells with IC₅₀ values ranging from 4.7 to 10.0 μg/mL, which were slightly more potent than doxorubicin. Their potency of cytotoxicities against MDR cancer cell lines (KB-C2 and K562/Adr) were similar to those against sensitive cell lines (KB and K562).     

Synthesis and greener pastures biological study of bis-thiadiazoles as potential Covid-19 drug candidates

A novel series of bis- (Abdelhamid et al., 2017, Banerjee et al., 2018, Bharanidharan et al., 2022)thiadiazoles was synthesized from the reaction of precursor dimethyl 2,2′-(1,2-diphenylethane-1,2-diylidene)-bis(hydrazine-1-carbodithioate) and hydrazonyl chlorides in ethanol under ultrasonic irradiation. Spectral tools (IR. NMR, MS, elemental analyses, molecular dynamic simulation, DFT and LUMO and HOMO) were used to elucidate the structure of the isolated products. Molecular docking for the precursor, 3 and ligands 6a-i to two COVID-19 important proteins M^pro and RdRp was compared with two approved drugs, Remdesivir and Ivermectin. The binding affinity varied between the ligands and the drugs. The highest recorded binding affinity of 6c with M^pro was (?9.2 kcal/mol), followed by 6b and 6a, (?8.9 and ?8.5 kcal/mol), respectively. The lowest recorded binding affinity was (?7.0 kcal/mol) for 6 g. In comparison, the approved drugs showed binding affinity (?7.4 and ?7.7 kcal/mol), for Remdesivir and Ivermectin, respectively, which are within the range of the binding affinity of our ligands. The binding affinity of the approved drug Ivermectin against RdRp recoded the highest (?8.6 kcal/mol), followed by 6a, 6 h, and 6i are the same have (?8.2 kcal/mol). The lowest reading was found for compound 3 ligand (?6.3 kcal/mol). On the other side, the amino acids also differed between the compounds studied in this project for both the viral proteins. The ligand 6a forms three H-bonds with Thr 319(A), Sr 255(A) and Arg 457(A), whereas Ivermectin forms three H-bonds with His 41(A), Gly143(A) and Gln 18(A) for viral M^pro. The RdRp amino acids residues could be divided into four groups based on the amino acids that interact with hydrogen or hydrophobic interactions. The first group contained 6d, 6b, 6 g, and Remdesivir with 1–4 hydrogen bonds and hydrophobic interactions 1 to 10. Group 2 is 6a and 6f exhibited 1 and 3 hydrogen bonds and 15 and 14 hydrophobic interactions. Group 3 has 6e and Ivermectin shows 4 and 3 hydrogen bonds, respectively and 11 hydrophobic interactions for both compounds. The last group contains ligands 3, 6c, 6 h, and 6i gave 1–3 hydrogen bonds and 6c and 3 recorded the highest number of hydrophobic interactions, 14 for both 6c and 6 h. Pro Tox-II estimated compounds’ activities as Hepatoxic, Carcinogenic and Mutagenic, revealing that 6f-h were inactive in all five similar to that found with Remdesivir and Ivermectin. The drug-likeness prediction was carried out by studying physicochemical properties, lipophilicity, size, polarity, insolubility, unsaturation, and flexibility. Generally, some properties of the ligands were comparable to that of the standards used in this study, Remdesivir and Ivermectin.     

Design,synthesis, docking and mechanistic studies of new thiazolyl/thiazolidinylpyrimidine-2,4-dione antiproliferative agents

In this article, we display on the synthesis and biological evaluation of a new series of thiazolylpyrimidine 3a-l and thiazolidinylpyrimidine derivatives 5a-e. The structures of the new compounds were confirmed by using different spectral techniques including NMR, IR, mass spectroscopy in addition to elemental analyses. The cell viability of the new compounds was assessed against normal human mammary gland epithelial (MCF-10A) cell line. Data revealed that none of the compounds examined exhibited cytotoxic effects, and the cell viability for the compounds examined at 50 µM was greater than 87%. The antiproliferative activity of 3a-l and 5a-e was evaluated against four human cancer cell lines where the compounds showed promising activity. The most potent derivatives were compounds 3a, 3c, 3f, 3i, and 5b with GI₅₀ values ranging from 0.90 µM to 1.70 µM against the four cancer cell lines in comparison to doxorubicin (GI₅₀ = 1.10 µM). Compounds 3a, 3c and 3i showed potent antiproliferative activity with dual inhibitory action against EGFR and BRAF^V600E. Compounds 3a, 3c, and 3i demonstrated promising AutoDock scores towards EGFR and BRAF^V600E with values of ? 9.1 and ? 8.6, ?9.0 and ? 8.5, and ? 8.4 and ? 8.0 kcal/mol, respectively. The physicochemical and pharmacokinetic characteristics of 3a, 3c, and 3i were anticipated, demonstrating their oral bioavailability.     

A combined experimental and theoretical study of metallic salts of thiapentadienyl, sulfinylpentadienyl and butadienesulfonyls

Alternative methods for the synthesis of the following acyclic salts (CH₂CHCHCHS)M [M = K, 1(K); Na, 1(Na); Li, 1(Li)], (CH₂CHCHCHSO)M [M = K, 2(K); Na, 2(Na)], (CH₂CHCHCHSO₂)M [M = K, 3(K); Na, 3(Na); Li, 3(Li)], (CH(Me)CHC(Me)CHSO₂)M [Me5-syn, M = K, 9(K); Na, 9(Na); Li, 9(Li), (CH(Me)CHCHC(Me)S)M [Me5-syn, M = K, 10(K); Na, 10(Na); Me5-anti, M = K, 11(K); Na, 11(Na)] are described, as a result of the activation of C-S bond in dihydrothiophenes by deprotonation with different bases. The effect of methyl substituents in the dihydrothiophenes is significant, which modifies considerably the choice of the base. The influence of the reaction conditions, type of solvent, base and dihydrothiophenes is analyzed. The NMR spectroscopy, including NOESY, ROESY and difference NOE establish the preferred U conformation for all derivatives, and support a delocalization of charge on the thiapentadienyl (1M) and sulfinylpentadienyl (2M) complexes. However, a conjugated diene structure is proposed on the butadienesulfonyl compounds (3M), in which the negative charge is delocalized in the SO₂ fragment and stabilized with the corresponding cations (M = K, Na and Li). In presence of traces of base, compounds 3M suffer a rearrangement, to the most stable S conformer, 13M. The stability of 3M depends on the size of the cation, the greater the size, the greater stability. Furthermore, a theoretical study shows that electronic and geometrical properties (energy conformers, charge distributions and relative stabilities) of the thiapentadienyl, sulfinylpentadienyl and butadienesulfonyl anions and their corresponding metal salts 1M-3M (M = Li, Na and K) shows to be in good agreement with the experimental findings.     

Design and synthesis of some novel pyridothienopyrimidine derivatives and their biological evaluation as antimicrobial and anticancer agents targeting EGFR enzyme

A new series of pyridothienopyrimidine derivatives was designed and evaluated as antimicrobial and anticancer agents. The target compounds were synthesized starting with 3-aminothieno[2,3-b]pyridine-2-carboxamide derivative 1 which underwent cyclocondensation reaction with aromatic aldehydes to give the key intermediates 2a,b. By further treatment of 2a,b with various reagents, the target 2,4-disubstituted-pyrido[3′,2′:4,5]thieno[2,3-d]pyrimidines 3a,b–11a,b were obtained. To evaluate the antimicrobial activity of the new compounds, they were tested against five bacterial and five fungal strains. Compounds 6c, 8b, 9a and 9b revealed the most significant antimicrobial activity against the tested microorganisms with MIC values range (4–16 μg/mL). Also, compounds 2a,b–11a,b were screened for their in vitro cytotoxic activity against HepG-2 and MCF-7 cancer cell lines compared with doxorubicin and cisplatin as references drugs. Moreover, compounds (2b, 4a, 6a, 7b, 7c and 9a) which exhibited the most potent anticancer activity, were further subjected to EGFR^WT enzyme inhibition assay utilizing erlotinib as a standard drug. The compounds 6a, 7b, 7c and 9a which showed the most promising suppression effects were also evaluated as inhibitors against the mutant forms EGFR^L858R and EGFR^T790M. The 4-aminopyrazolone analogue 9a showed superior anticancer activity against both HepG-2 and MCF-7 cell lines (IC50 = 1.27, 10.80 μM, respectively) and more potent enzymatic inhibition activity against EGFR^WT and its mutant forms EGFR^L858R and EGFR^T790M than that obtained by erlotinib (IC₅₀ = 0.021, 0.053, 0.081 µM, respectively, IC_50erlotinib; 0.027, 0.069, 0.550 µM, respectively). Finally, the molecular docking study showed good binding patterns of the most active compounds with the prospective target EGFR^WT.     

Synthesis,characterization and metal ion complexation and extraction capabilities of calix[4]arene Schiff base compounds

The syntheses, characterization and metal ion complexation and extraction capabilities of six new calix[4]arene Schiff base compounds, 5–10, are reported. The preparation of the compounds was achieved by the condensation of 5,17-diamino-11,23-di-tert-butyl-25,27-di-n-butoxy-26,28-dihydroxycalix[4]arene with the appropriate aldehyde (5-bromosalicylaldehyde for 5, 4-anisaldehyde for 6, 4-(dimethylamino)benzaldehyde for 7, 9-anthracenecarboxaldehyde for 8, 1-pyrenecarboxaldehyde for 9, and 9-fluorenecarboxaldehyde for 10) in refluxing ethanol. The compounds were characterized by ¹H and ¹³C NMR spectroscopy, IR spectroscopy, high-resolution mass spectrometry and elemental analysis. The X-ray crystal structures of 7, 8 and 9 (as dichloromethane solvates) revealed that the calixarene molecules adopt H-bond stabilized, distorted-cone conformations and form centrosymmetric dimers in the solid state. Compounds 5–10 did not form host–guest complexes with NEt₄[(bdt)MoO₂(OSiPh₃)] (bdt^2–=benzene-1,2-dithiolate), a potential precursor for biologically relevant oxosulfido-Mo(VI/V) enzyme models; such host–guest complexes have the potential to stabilize these sought-after but highly reactive model compounds. In addition, the capabilities of 5–10 to extract selected metal ions (Ni²⁺, Co²⁺, Cu²⁺, Zn²⁺, Ag⁺, Pb²⁺, Cd²⁺ and Hg²⁺) from an aqueous into an organic phase have been assessed by picrate extraction experiments. Compound 5 displayed exceptional selectivity towards Ni²⁺, compound 7 exhibited enhanced extraction towards all of the metal ions tested and compounds 6, 9 and 10 showed very high selectivity towards Hg²⁺. On the other hand, compound 8 exhibited negligible capacity to extract any of the metal ions tested.     

Synthesis and structures of the dinuclear tin(II) complexes [R = Ph, X(Z) = CPh; R = SiMe3, X(Z) = PPh2] and of related compounds

Tin(II) compounds containing the ligands [CH(C₆H₃Me₂-2,5)C(Bu^t)NSiMe₃]⁻ (≡ L¹), [CH(Ph)C(Ph)NSiMe₃]⁻ (≡L²), [CH(SiMe₃)P(Ph)₂NSiMe₃]⁻ (≡ L³),

Full-size image (3K)

(≡ L⁴), [C(Ph)C(Ph)NSiMe₃]²⁻ (≡ L⁵), and [C(SiMe₃)P(Ph)₂NSiMe₃]²⁻ (≡ L⁶) are reported: the transient SnBr(L¹) (1) and SnBr(L²) (2), Sn(L¹)₂ (3) [P.B. Hitchcock, J. Hu, M.F. Lappert, M. Layh, J.R. Severn, J. Chem. Soc., Chem. Commun. (1997) 1189], the labile Sn(L²)₂ (4), [Sn(L⁵)]₂ (5), SnCl(L³) (6), Sn(L³)₂ (7), [Sn(L⁶)]₂ (8), Sn(L⁴)₂ (9) and Pb(L⁴)₂ (10). They were prepared from (i) SnBr₂ and K(L¹) (1, 3) or K(L²) (2, 4, 5); (ii) SnCl₂ and Li(L³) (6–9); or (iii) PbCl₂ and Li(L⁴) (10). Each of 1, 3 and 5–10 has been characterised by multinuclear NMR spectra; 3, 5, 6, 8, 9 and 10 by EI-mass spectra, but only 3, 5, 8, 9 and 10 were isolated pure and furnished X-ray quality crystals. Of greatest novelty are the title binuclear fused tricyclic ladder-like compounds 5 and 8. Quantum chemical calculations, on alternative pathways to 5 from 2 and to 8 from 7, are reported.     

Structural phase transition and magnetic properties of layered organic-inorganic hybrid compounds: p-Haloanilinium tetrachlorocuparate(II)

Compounds of the general formula A₂CuCl₄, (where A = 4-fluoroanilinium (1) and 4-chloroanilinium (2)) were prepared, structurally characterized and their thermal and magnetic properties studied. These compounds have a layered structure, distorted perovskite, where layers of CuCl₄²⁻ are sandwiched between a 4-haloanilinium cation bilayer. A single crystal X-ray diffraction study on (4-fluoroanilinium)₂CuCl₄, (1), shows that it crystallizes in the monoclinic P2₁/c space group with cell dimensions a = 15.5113(5) Å, b = 7.3788(2) Å, c = 7.0929(2) Å, β = 99.004(2)°, volume 801.81(4) Å³ at 150 K. Compound 2, (4-chloroanilinium)₂CuCl₄, crystallizes isostructurally to 1 at RT, but at 150 K it adopts the Pccn space group. This structural transition for 2 is reversible, and has been observed using Differential Scanning Calorimetric (DSC) measurements. The dc-magnetic studies using a SQUID magnetometer suggest that both compounds are soft ferromagnets and show an onset of long range magnetic ordering below 9 K. The ac-susceptibility measurements confirm the presence of this ferromagnetic ordering in both the compounds.     

Antitubercular and antioxidant activities of hydroxy and chloro substituted chalcone analogues: Synthesis,biological and computational studies

A series of chalcone analogues (1–15) were synthesized by Claisen-Schmidt condensation in good yields (70–95%) and characterized by FT-IR, ¹H NMR and mass spectral methods. Additionally, compounds 3 and 7 were characterized by ¹³C NMR. Antitubercular and antioxidant activities of the chalcones were evaluated by MABA and DPPH free radical assays. In MABA assay analogues 3 (MIC = 14 ± 0.11 µM) and 11 (MIC = 14 ± 0.17 µM) bearing fluorine and methoxy groups at para and meta positions were 1.8-times more active than the standard pyrazinamide (MIC = 25.34 ± 0.22 µM). The chalcone analogues such as compound 7 (IC₅₀ = 4 ± 1 µg/mL) containing electron releasing groups such as OH at ortho position had slightly more antioxidant activity than Gallic acid (IC₅₀ = 5 ± 1 µg/mL). The potential compounds 3, 7, 9 and 11 were less selective and toxic against human live cell lines-LO2. Further, molecular docking results of chalcones against anti-tubercular drug target isocitrate lyase (PDB ID: 1F8M) revealed that compound 3 and 11 shown least binding energies as ?7.6, and ?7.5 kcal/mol are in line with in vitro MABA assay, suggesting that these compounds 3 and 11 are strong inhibitor of isocitrate lyase. SwissADME programme estimated the drug likeliness properties of compounds 3, 7, 9 and 11. The lead molecules arisen through this study helps to develop new antitubercular and antioxidant agents.     

Stereochemistry of atropisomeric 9,10-dihydrophenanthrene dimers from Pholidota chinensis

Nine bis-9,10-dihydrophenanthrene and 9,10-dihydrophenanthrene/(dihydro)stilbene derivatives, including the new phochinenins G-L 1–6, were isolated from the whole plant of Pholidota chinensis. Their structures were elucidated on the basis of extensive spectroscopic investigations (1D, 2D NMR, and HR-EIMS). Owing to the sterically hindered rotation around the biaryl axis, some of these biaryl compounds can exist as a pair of enantiomers, but were isolated as racemates. Computed inversion barriers of selected atropisomeric derivatives suggested that phochinenins K 5, gymconpin C 7, and flavanthrin 9 have stable atropisomers. Their racemates were separated by HPLC on an optically active stationary phase, and were stereochemically characterized on-line by circular dichroism (CD) spectroscopy (LC-CD coupling), in conjunction with quantum-mechanics CD calculations.     

Synthesis,anticancer, molecular docking and QSAR studies of benzoylhydrazone

To find out effective anticancer compounds we synthesized (1–30) derivatives of 4-isopropylbenzoylhydrazone and evaluated for anticancer potential. The compounds 3, 9, 12, 23, 26 and 28 showed better activities ranging (0.39–1.1 µg/ml) than the standard (1.53 ± 0.01 µg/ml). In line with this, compounds 2, 6, 24, 25 and 29 exhibited better activities compared to the second standard (5FU 4.60 ± 0.01 µg/ml). The best molecular docked complex between the BRCA1 structure and the 1–30 derivatives were analyzed based on the Glide docked score and binding orientation for both the SP and XP mode. The 2D-QSAR analysis reflected a significant correlation between the experimental and the predicted biological activities. The above-mentioned compounds were also assessed by various spectroscopic techniques.     

An efficient one-pot three-component synthesis of 2-(4-(2-oxo-2H-chromen-3-yl)thiazol-2-yl)-3-arylacrylonitriles and their cytotoxic activity evaluation with molecular docking

A facile, convenient and one-pot three-component method has been outlined for the synthesis of title compounds by treating equimolar amounts of 3-(2-bromoacetyl)-2H-chromen-2-one (2) with 2-cyanothioacetamide (3) and various aryl/heteryl aldehydes (5 or 7) independently. The effect of solvent and catalyst on this one-pot reaction has been studied and the use of l-proline in ethanol was found to be effective to achieve the target compounds (6 & 8) in fair yields. These synthesized compounds were further assessed for the anti-hepatoma activity, and their action mechanism was also investigated by using molecular docking studies. All the compounds 6(a-h) & 8(a-f) manifested excellent potency for anti-hepatoma activity. It should be noted that, compounds 6e, 6f have exhibited almost equipotent activity with reference to standard drug Nexavar.